Figure 7: In vivo anticancer effects of BN spheres by using orthotopically injected models.
From: Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment
(a) Mouse weight for different groups 12 weeks after LNCap cancer cell injection at the dose of 2 × 106 cells per mouse (n=4); (b) quantitative analysis of the effects of different samples on tumour size at the end point (data are shown as mean±s.d., t-test, *P<0.05, n=4).
